Tony Michael Argenbright

Array ( [id] => 531542 [patent_doc_number] => 07179785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => 'Compounds that bind to p185 and methods of using the same' [patent_app_type] => utility [patent_app_number] => 10/301499 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 20995 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179785.pdf [firstpage_image] =>[orig_patent_app_number] => 10301499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999575 [patent_doc_number] => 06911426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-28 [patent_title] => 'Methods and compositions for derepression of IAP-inhibited caspase' [patent_app_type] => utility [patent_app_number] => 10/302811 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 122 [patent_figures_cnt] => 122 [patent_no_of_words] => 27931 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911426.pdf [firstpage_image] =>[orig_patent_app_number] => 10302811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 515594 [patent_doc_number] => 07192922 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Method of treating left ventricular dysfunction' [patent_app_type] => utility [patent_app_number] => 10/299162 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 20 [patent_no_of_words] => 3857 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/192/07192922.pdf [firstpage_image] =>[orig_patent_app_number] => 10299162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7208648 [patent_doc_number] => 20050053597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Composition and method for treatment of wounds' [patent_app_type] => utility [patent_app_number] => 10/495740 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3634 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053597.pdf [firstpage_image] =>[orig_patent_app_number] => 10495740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847339 [patent_doc_number] => 20030166506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Method of producing n-[(2S)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl]-L-leucyl-L-tert-leucine N-methylamide and intermediate thereof' [patent_app_type] => new [patent_app_number] => 10/295652 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3089 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166506.pdf [firstpage_image] =>[orig_patent_app_number] => 10295652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684168 [patent_doc_number] => 20030120032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'N-methyl-homocysteines and their use as well as process for their production' [patent_app_type] => new [patent_app_number] => 10/295043 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5309 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20030120032.pdf [firstpage_image] =>[orig_patent_app_number] => 10295043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748348 [patent_doc_number] => 20060111280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Novel substance fki-1033 and process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/532662 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4030 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111280.pdf [firstpage_image] =>[orig_patent_app_number] => 10532662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682710 [patent_doc_number] => 20030118574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Pharmaceutical composition comprising factor VII polypeptides and TAFI Polypeptides' [patent_app_type] => new [patent_app_number] => 10/290814 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18242 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118574.pdf [firstpage_image] =>[orig_patent_app_number] => 10290814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847405 [patent_doc_number] => 20030166572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => '2-Amino-3-hydroxy-4-tert-leucyl-amino-5 phenyl-pentanoic acid amide derivatives' [patent_app_type] => new [patent_app_number] => 10/258901 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15923 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166572.pdf [firstpage_image] =>[orig_patent_app_number] => 10258901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870551 [patent_doc_number] => 20030083241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation' [patent_app_type] => new [patent_app_number] => 10/280517 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22804 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083241.pdf [firstpage_image] =>[orig_patent_app_number] => 10280517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7137238 [patent_doc_number] => 20040044405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same' [patent_app_type] => new [patent_app_number] => 10/280576 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7714 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044405.pdf [firstpage_image] =>[orig_patent_app_number] => 10280576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 460180 [patent_doc_number] => 07241796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => 'Inhibitors of serine proteases, particularly HCV NS3-NS4A protease' [patent_app_type] => utility [patent_app_number] => 10/280940 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17931 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241796.pdf [firstpage_image] =>[orig_patent_app_number] => 10280940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 489802 [patent_doc_number] => 07214662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-08 [patent_title] => 'Injectable solution of an LHRH antagonist' [patent_app_type] => utility [patent_app_number] => 10/279625 [patent_app_country] => US [patent_app_date] => 2002-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1202 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/214/07214662.pdf [firstpage_image] =>[orig_patent_app_number] => 10279625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856672 [patent_doc_number] => 20030130173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => new [patent_app_number] => 10/269471 [patent_app_country] => US [patent_app_date] => 2002-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17249 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130173.pdf [firstpage_image] =>[orig_patent_app_number] => 10269471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766191 [patent_doc_number] => 20030100591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Methods of treatment of uterine pathological conditions' [patent_app_type] => new [patent_app_number] => 10/267129 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10193 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100591.pdf [firstpage_image] =>[orig_patent_app_number] => 10267129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6834284 [patent_doc_number] => 20030161829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'IGF-binding protein-derived peptide or small molecule' [patent_app_type] => new [patent_app_number] => 10/264672 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16238 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20030161829.pdf [firstpage_image] =>[orig_patent_app_number] => 10264672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774183 [patent_doc_number] => 08119590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Prevention and treatment of restenosis by local administration of drug' [patent_app_type] => utility [patent_app_number] => 10/260094 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12588 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119590.pdf [firstpage_image] =>[orig_patent_app_number] => 10260094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 914502 [patent_doc_number] => 07326685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/490326 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18112 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326685.pdf [firstpage_image] =>[orig_patent_app_number] => 10490326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1123738 [patent_doc_number] => 06794364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-21 [patent_title] => 'Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides' [patent_app_type] => B2 [patent_app_number] => 10/251018 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9787 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/794/06794364.pdf [firstpage_image] =>[orig_patent_app_number] => 10251018 [rel_patent_id] =>[rel_patent_doc_number] =>)